Orbit Discovery

Oxford, United Kingdom Founded: 2015 • Age: 11 yrs
Drug discovery platform developed using peptide display engine.

About Orbit Discovery

Orbit Discovery is a Healthcare company based in Oxford (United Kingdom) founded in 2015. Drug discovery platform developed using peptide display engine. Orbit Discovery has raised $15.73 million across 4 funding rounds from investors including Oxford Technology, Oxford University Innovation and Innovate UK. The company has 26 employees. Its chief executive, as recorded, is Neil Butt. Orbit Discovery offers products and services including Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ORBIT DISCOVERY LTD. Its competitors include Antiverse and LabGenius; 1 of its 2 listed competitors has raised funding.

Company details

Developer of a drug discovery platform by the peptide display engine. The technology uses phage display to find novel natural peptides and present it to the desired target and mRNA display for natural peptides. It has a DNA library that encodes for the peptides and each DNA is attached to a single bead, after a long process of emulsion PCR, transcription, and translation the synthesized peptides are presented to the target for screening.

  • Headquarters Oxford, United Kingdom
  • Employees 26
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website orbitdiscovery.com
  • Social LinkedIn X
  • Legal Name Orbit Discovery Ltd
  • Date of Incorporation 01 Sep, 2020
  • Jurisdiction OXFORD, OXFORDSHIRE, UNITED KINGDOM
Key Metrics
  • Total Equity Funding
    $15.73M (USD)

    in 4 rounds

  • Latest Funding Round
    $580.97K (USD), Grant

    Jun 2022

  • Investors
  • Employee Count
    26

Products & Services of Orbit Discovery

Orbit Discovery offers a comprehensive portfolio of products and services, including Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services.

Bead-based Display System
Screening Technology

High-throughput platform for peptide discovery and affinity screening

Microfluidics Screening
Functional Screening

System for direct functional testing of peptides in therapeutic applications

Peptide Conjugate Services
Therapeutic Development

Services for identifying peptide ligands for targeted drug delivery

Funding Insights of Orbit Discovery

Orbit Discovery has successfully raised a total of $15.73M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $580.97 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $15.73M
  • Total Rounds 4
  • Last Round Grant β€” $580,971
  • Investors Count 9

All 4 funding rounds of Orbit Discovery with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022$580,971Grant––
Jul 2021$7.6MSeries A–Oxford Science Enterprises
May 2018$8.13MSeries A–Oxford Science Enterprises
Jan 2016Seed––
Valuation history

9 investors in total: 8 institutional and 1 angel.

Investors in Orbit Discovery

Orbit Discovery has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Oxford Technology, Oxford University Innovation and Innovate UK.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investment management services for science ventures are provided in Oxford.
oxfordscienceenterprises.comOxford, United Kingdom
Venture capital firm investing in seed & series A startups
borealis.vcHanover, United States
Startups are incubated by Oxford University Innovation.
1987innovation.ox.ac.ukOxford, United Kingdom
Early-stage micro-VC investments are focused on UK companies.
1983oxfordtechnology.com
innovateuk.gov.uk
Venture investment trust funding tech startups with positive social impact.
2016perivoliinnovations.comUnited Kingdom
Provides comprehensive IT services including support, maintenance, and security.
2011rtventures.co.ukGlasgow, United Kingdom
Invests in seed to Series C funding for science-based startups from UK institutions.
2015oxfordinvestmentconsultants.comBanbury, United Kingdom

Kapil Dev Joory

Angel investor and entrepreneur, focusing on tech startups in India.
unknown_4a0a181bca1241309
Premium access

Investor details for Orbit Discovery

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Orbit Discovery

20 people are tracked at Orbit Discovery (6 in leadership, 14 in team); the tracked headcount is 26.

NameRoleGroup
Neil Butt
CEOLeadership
Brett Rowley
VP Of FinanceLeadership
Simon Bushell
Head of Target DevelopmentLeadership
Anthony Pitt
CTOLeadership
Tracy Lane
Head of Platform DevelopmentLeadership
Caroline W.
Head of Technology DevelopmentLeadership
Gillian Donachie
Operations ManagerTeam
Xiaoju Ni
Principal Scientist, Team leadTeam
Mark Peacock
Research And Development Scientist IITeam
Eseoghene Ifie Mmedsci
Scientist IITeam
Eirini Xemantilotou
Senior ScientistTeam
Luca Pignata
Senior ScientistTeam
Jiraporn Lueangsakulthai
Senior ScientistTeam
Farnaz Hajizadeh
Scientist ITeam
Sebastien Lavielle
Principal ScientistTeam
Giovanna Cacciola
Principal ScientistTeam
Jinous Samavat
Senior ScientistTeam
Maria Episcopou
Scientist ITeam
Rosie Little
Senior ScientistTeam
Samantha Smith
Office AdministratorTeam
Premium access

Complete people profiles for Orbit Discovery

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Orbit Discovery

3 dated milestones of Orbit Discovery across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Orbit Discovery is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $581K.

Competitors of Orbit Discovery

Orbit Discovery has 2 listed competitors in our database, 1 of them funded. They include Antiverse and LabGenius.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
antiverse.io2017Cardiff, United Kingdom$9.58M7
An AI platform for antibody drug discovery is provided.
labgeni.us2012London, United Kingdom54
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
Premium access

Detailed competitors of Orbit Discovery

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Orbit Discovery

The website of Orbit Discovery (orbitdiscovery.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Orbit Discovery (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Orbit Discovery

Premium access

Complete news archive for Orbit Discovery

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orbit Discovery

Orbit Discovery was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Orbit Discovery is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.

Neil Butt is the CEO of Orbit Discovery, as recorded in our data.

Orbit Discovery is a funded company, having raised a total of $15.73M across 4 funding rounds to date.

Orbit Discovery has 26 employees.

Developer of a drug discovery platform by the peptide display engine. The technology uses phage display to find novel natural peptides and present it to the desired target and mRNA display for natural peptides. It has a DNA library that encodes for the peptides and each DNA is attached to a single bead, after a long process of emulsion PCR, transcription, and translation the synthesized peptides are presented to the target for screening.

Orbit Discovery's top competitors include Antiverse and LabGenius.

Orbit Discovery offers Bead-based Display System, Microfluidics Screening, and Peptide Conjugate Services.

Orbit Discovery has 9 investors. Key investors include Oxford Technology, Oxford University Innovation, Innovate UK, Oxford Science Enterprises, and Borealis Ventures.

Orbit Discovery operates through Orbit Discovery Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available